Monoclonal Antibodies and Fc‐Fusion Proteins for Pediatric Use: Dosing, Immunogenicity, and Modeling and Simulation in Data Submitted to the US Food and Drug Administration

The experience with the use of monoclonal antibodies and Fc‐fusion proteins (mAb/Fc) in the pediatric population is limited. The objective of this study is to review those factors impacting the clinical efficacy and product safety of mAb/Fc products in pediatric patients during drug development. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaomei I., Dallmann, André, Wang, Yow‐Ming, Green, Dionna J., Burnham, Janelle M., Chiang, Beatrice, Wu, Perry, Sheng, Mark, Lu, Kelley, van den Anker, John N., Burckart, Gilbert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Pediatric Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617747/
https://www.ncbi.nlm.nih.gov/pubmed/30865317
http://dx.doi.org/10.1002/jcph.1406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617747/
https://www.ncbi.nlm.nih.gov/pubmed/30865317
http://dx.doi.org/10.1002/jcph.1406

Ejemplares similares